相关实验视频

Updated: Jun 13, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

血液参数的多变量分析用于预测部骨折患者的死亡率

Turan Cihan Dülgeroğlu¹, Mehmet Kurt¹, Alaaddin Oktar Üzümcigil¹

¹Department of Orthopedics and Traumatology, Kütahya Health Sciences University Faculty of Medicine, 43020 Kütahya, Turkey.

Experimental and therapeutic medicine

|September 13, 2024

概括

这项研究发现,心率恢复 (HRR) 可以预测关节骨折患者的死亡率,而血小板与淋巴细胞的比率 (PLR) 可以预测关节骨折的整体死亡率. 这些血液参数为患者的治疗结果提供了宝贵的见解.

科学领域:

整形外科整形外科整形外科
血液学血液学血液学
老年学是指老年学的学科.

背景情况:

部骨折是致病率和死亡率的重要原因,特别是在老年人中.
确定可靠的死亡率预测因素对于及时干预和改善患者管理至关重要.
现有的研究已经探索了各种临床和生化标志物,但需要进一步研究血液参数.

研究的目的:

评估各种血液参数的预测值及其与部骨折患者死亡率的比率.
确定特定血液学指数与骨骨折后的短期 (<1个月) 和长期 (>12个月) 死亡率之间的关联.
用灵敏度和特异性来评估已识别的预测因子的诊断性能.

主要方法:

一个回顾性横截面研究,包括758名患有部骨折的患者.
患者被分为死亡率 (n=464) 和幸存者 (n=294) 组.
进行了统计分析,以比较不同组的血液参数 (例如,RDW,MPV,HGB,EOS,HRR,PLR) 并确定其预测值.

主要成果:

一些血液参数,包括平均血小板体积 (MPV),血红蛋白 (HGB),乙氨基酸计数 (EOS),心率恢复 (HRR) 和血小板与淋巴细胞比率 (PLR),在死亡率组显著更高.
HRR对整体关节骨折相关死亡率和30天死亡率具有显著的预测价值.
发现PLR是整体关节骨折相关死亡率的重要预测因素.

结论:

心率恢复 (HRR) 显示出潜力作为骨折后死亡率的预测标志物,包括短期结果.
血小板与淋巴细胞比率 (PLR) 是整体关节骨折相关死亡率的有价值预测指标.
这些发现凸显了特定血液参数在关节骨折患者风险分层中的有用性.

关键词:

血液参数血液参数部骨折骨折部骨折部骨折死亡率死亡率预测价值是一个预测值.

更多相关视频

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

Method and Instrumented Fixture for Femoral Fracture Testing in a Sideways Fall-on-the-Hip Position

Method and Instrumented Fixture for Femoral Fracture Testing in a Sideways Fall-on-the-Hip Position

Published on: August 17, 2017

相关概念视频

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...